Mirko Buttrini

Dr. Mirko Buttrini

Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
Adriana CalderaroAdriana Calderaro
Adriana Calderaro
Mirko ButtriniMirko Buttrini
Mirko Buttrini
BFBenedetta Farina
Benedetta Farina
Sara MontecchiniSara Montecchini
Sara Montecchini
FCFlora De Conto
Flora De Conto
CCCarlo Chezzi
Carlo Chezzi
Respiratory tract infections (RTIs) are the focus of developments in public health, given their widespread distribution and the high morbidity and mortality rates reported worldwide. The clinical spectrum ranges from asymptomatic or mild infection to severe or fatal disease. Rapidity is required in diagnostics to provide adequate and prompt management of patients. The current algorithm for the laboratory diagnosis of RTIs relies on multiple approaches including gold-standard conventional methods, among which the traditional culture is the most used, and innovative ones such as molecular methods, mostly used to detect viruses and atypical bacteria. The implementation of molecular methods with syndromic panels has the potential to be a powerful decision-making tool for patient management despite requiring appropriate use of the test in different patient populations. Their use radically reduces time-to-results and increases the detection of clinically relevant pathogens compared to conventional methods. Moreover, if implemented wisely and interpreted cautiously, syndromic panels can improve antimicrobial use and patient outcomes, and optimize laboratory workflow. In this review, a narrative overview of the main etiological, clinical, and epidemiological features of RTI is reported, focusing on the laboratory diagnosis and the potentialities of syndromic panels.

1 January 2021 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
Adriana CalderaroAdriana Calderaro
Adriana Calderaro
FCFlora De Conto
Flora De Conto
Mirko ButtriniMirko Buttrini
Mirko Buttrini
GPGiovanna Piccolo
Giovanna Piccolo
SMSara Montecchini
Sara Montecchini
CCCarlo Chezzi
Carlo Chezzi
The aim of this study was to determine the prevalence of respiratory virus infections, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), during the winter period December 2019 to March 2020, via a tertiary care hospital-based survey in Parma, Northern Italy. A total of 906 biological samples from the respiratory tract were analysed by both conventional assays (including culture) and molecular assays targeting nucleic acids of SARS-CoV-2 and other respiratory viruses. Overall, 474 samples (52.3%) were positive for at least one virus, with a total of 583 viruses detected. Single infections were detected in 380 (80.2%) samples and mixed infections were detected in 94 (19.8%). Respiratory syncytial virus (138/583, 23.7%) and rhinovirus (130/583, 22.3%) were the most commonly identified viruses, followed by SARS-CoV-2 (82/583, 14.1%). Respiratory syncytial virus predominated until February, with 129 detections; it then decreased drastically in March to only nine detections. SARS-CoV-2 was absent in the study area until February 26, 2020 and then reached 82 detections in just over a month. SARS-CoV-2 was found in mixed infections in only three cases, all observed in children younger than 1 year old. This study showed a completely different trend between SARS-CoV-2 and the ‘common’ respiratory viruses: the common viruses mostly affected children, without any distinction according to sex, while SARS-CoV-2 mostly affected adult males.

Verified
Journal Article
Open access
PDF file
Adriana CalderaroAdriana Calderaro
Adriana Calderaro
FMFederica Motta
Federica Motta
Sara MontecchiniSara Montecchini
Sara Montecchini
CGChiara Gorrini
Chiara Gorrini
GPGiovanna Piccolo
Giovanna Piccolo
FCFlora De Conto
Flora De Conto
Despite that matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (MS) has become a powerful tool in the clinical microbiology setting, few studies have till now focused on MALDI-TOF MS-based identification of dermatophytes. In this study, we analyze dermatophytes strains isolated from clinical samples by MALDI-TOF MS to supplement the reference database available in our laboratory. Twenty four dermatophytes (13 reference strains and 11 field isolated strains), identified by both conventional and molecular standard procedures, were analyzed by MALDI-TOF MS, and the spectra obtained were used to supplement the available database, limited to a few species. To verify the robustness of the implemented database, 64 clinical isolates other than those used for the implementation were identified by MALDI-TOF MS. The implementation allowed the identification of the species not included in the original database, reinforced the identification of the species already present and correctly identified those within the Trichophyton mentagrophytes complex previously classified as Trichophyton. tonsurans by MALDI-TOF MS. The dendrogram obtained by analyzing the proteic profiles of the different species of dermatophytes reflected their taxonomy, showing moreover, in some cases, a different clusterization between the spectra already present in the database and those newly added. In this study, MALDI-TOF MS proved to be a useful tool suitable for the identification of dermatophytes for diagnostic purpose.

4 January 2018 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
Adriana CalderaroAdriana Calderaro
Adriana Calderaro
Mirko ButtriniMirko Buttrini
Mirko Buttrini
Sara MontecchiniSara Montecchini
Sara Montecchini
SRSabina Rossi
Sabina Rossi
GPGiovanna Piccolo
Giovanna Piccolo
FCFlora De Conto
Flora De Conto
In this study for the first time, a Dientamoeba fragilis protein profile by MALDI-TOF MS was created in order to identify specific markers for the application of this technology in the laboratory diagnosis of dientamoebiasis. In particular, one D. fragilis reference strain was used to create a reference spectrum and 14 clinical isolates to verify the reliability of the obtained results. While 15 peaks were found to be discriminating between the reference strain and the culture medium used, six peaks, observed in all the 14 strains tested, were considered as markers able to identify D. fragilis. In our hands, MALDI-TOF MS technology was demonstrated as a useful tool to be used in association with or in replacement of the real-time PCR assay for the identification of D. fragilis used in our laboratory on xenic cultures, due to its accuracy, rapidity and low cost.

2 June 2014 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
Adriana CalderaroAdriana Calderaro
Adriana Calderaro
GPGiovanna Piccolo
Giovanna Piccolo
CGChiara Gorrini
Chiara Gorrini
Sara MontecchiniSara Montecchini
Sara Montecchini
Mirko ButtriniMirko Buttrini
Mirko Buttrini
MMMaria Cristina Medici
Maria Cristina Medici
Leptospirosis, a spirochaetal zoonotic disease of worldwide distribution, endemic in Europe, has been recognized as an important emerging infectious disease, though yet it is mostly a neglected disease which imparts its greatest burden on impoverished populations from developing countries. Leptospirosis is caused by the infection with any of the more than 230 serovars of pathogenic Leptospira sp. In this study we aimed to implement the MALDI-TOF mass spectrometry (MS) database currently available in our laboratory with Leptospira reference pathogenic (L. interrogans, L. borgpetersenii, L. kirschneri, L. noguchii), intermediate (L. fainei) and saprophytic (L. biflexa) strains of our collection in order to evaluate its possible application to the diagnosis of leptospirosis and to the typing of strains. This was done with the goal of understanding whether this methodology could be used as a tool for the identification of Leptospira strains, not only at species level for diagnostic purposes, but also at serovar level for epidemiological purposes, overcoming the limits of serological and molecular conventional methods. Twenty Leptospira reference strains were analysed by MALDI-TOF MS. Statistical analysis of the protein spectra was performed by ClinProTools software.

31 October 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
Adriana CalderaroAdriana Calderaro
Adriana Calderaro
Sara MontecchiniSara Montecchini
Sara Montecchini
Mirko ButtriniMirko Buttrini
Mirko Buttrini
GPGiovanna Piccolo
Giovanna Piccolo
SRSabina Rossi
Sabina Rossi
CCCarlo Chezzi
Carlo Chezzi
Accurate, prompt, and reliable tools for the diagnosis of malaria are crucial for tracking the successes or drawbacks of control and elimination efforts, and for future programs aimed at global malaria eradication. Although microscopy remains the gold standard method, the number of imported malaria cases and the risk of reappearance of autochthonous cases stimulated several laboratories located in European countries to evaluate methods and algorithms suited to non-endemic settings, where skilled microscopists are not always available. In this review, an overview of the field evaluation and a comparison of the methods used for the diagnosis of malaria by European laboratories is reported, showing that the development of numerous innovations is continuous. In particular, the combination of rapid diagnostic tests and molecular assays with microscopy represents a reliable system for the early diagnosis of malaria in non-endemic settings.